Delivery Order SPE2DR25D1002-SPE2DR26FGJ9K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,395.14 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of November 7, 2025. The award, issued on November 6, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a $1,129.62 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 23, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.81 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 28, 2025. This non-set-aside, competitively awarded contract reflects firm fixed-price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion through December 2026. The place of performance is located at...
- The Defense Logistics Agency has awarded a delivery order totaling $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. This contract is not set-aside and was competitively awarded to the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,595.56 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this pharmaceutical supply delivery. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $2,423.27 to supply Valtoco 5 mg nasal sprays, with a completion deadline of June 2, 2025. This competitively awarded, non-set-aside contract uses firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,863.96 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract will be performed at the vendor's corporate office location in Conshohocken, PA 19428. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays under a firm fixed price contract valued at $2,187.24. The award, issued on November 17, 2025, represents a non-competitive delivery order with an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $1,760.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for Valtoco 10 mg nasal sprays, with completion scheduled for November 17, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGJ9KDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,093.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of November 19, 2025. This firm fixed-price contract, issued on November 18, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders through its IDC for medications and medical supplies supporting defense and veteran healthcare needs. This Valtoco order exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains. The contract demonstrates AmerisourceBergen's competitive standing within the DLA's pharmaceutical procurement strategy, which is transitioning toward the Pharmaceutical Prime Vendor Global Program Generation V with anticipated multiple awards across separate regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/18/25 |